Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 54 of 54 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/11/17
End: 07/12/21
Due: 07/12/22
Phase: N/A
Priority: Normal
Start: 07/14/14
End: 09/15/17
Due: 09/15/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer | NCT00080028 | Pharmacyclics LLC. | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) | NCT00054795 | Pharmacyclics LLC. | user2@example.com | None | - | - | - | - | - | 2025-07-14 |
| Ibrutinib in Combination With Corticosteroids vs Placebo in Combination With Corticosteroids in Participants With New Onset Chronic Graft Versus Host Disease (cGVHD) | NCT02959944 | Pharmacyclics LLC. | user2@example.com | None | 2017-05-11 | 2021-07-12 | 2022-07-12 | - | - | 2025-07-14 |
| Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease | NCT02195869 | Pharmacyclics LLC. | user2@example.com | None | 2014-07-14 | 2017-09-15 | 2018-09-15 | - | - | 2025-07-14 |